ATTUNE Rotating Platform (RP) Total Knee System, ATTUNE Cementless Rotating Platform (RP) Knee System, ATTUNE Revision R
Depuy, Inc. · Decision date Sep 9, 2026
What did the FDA decide?
FDA recorded decision OK30 on 2026-09-09 for P830055/S372, a 30-day notice under the supplement reason "Process Change - Manufacturer/Sterilizer/Packager/Supplier." The stated change is the addition of an ingos sub-tier supplier that provides titanium powder used in 3D printing processes for some components of the ATTUNE Rotating Platform (RP) Total Knee System, ATTUNE Cementless Rotating Platform (RP) Knee System and ATTUNE Revision Rotating Platform (RP) Knee System. The applicant is Depuy, Inc., and the statement places this activity at the DePuy (Ireland) and Paragon Medical, Inc facilities.
The identifier links this filing to the existing P830055 approval as a supplement rather than an original PMA. The notice describes supply and process scope only; it does not establish safety, clinical effectiveness or any new indication, and the source statement does not specify which individual components use the added supplier, the quantity of powder involved or any verification or validation detail.
The product category listed is a semi-constrained, metal/polymer, mobile-bearing patellofemoral tibial knee prosthesis under product code NJL, specialty Orthopedic.
FDA approval order statement
an addition of ingos sub-tier supplier for a supplier providing titanium powder for the 3D printing processes for some ATTUNE Rotating Platform (RP) Total Knee System, ATTUNE Cementless Rotating Platform (RP) Knee System, and ATTUNE Revision Rotating Platform (RP) Knee System components at the DePuy (Ireland) and Paragon Medical, Inc facilities
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Orthopedic
- Decision date
- Sep 9, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P830055/S372
- Regulatory pathway
- PMA supplement
- Applicant
- Depuy, Inc.
- Product code
- NJL
- Decision code
- OK30
- Decision date
- Sep 9, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing.
- Applicant
- Depuy, Inc.
- Product code
- NJL
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P830055/S372 received
Application receipt date recorded by FDA.
P830055/S374 · Related supplement
LCS(R) TOTAL KNEE SYSTEM, specifically ATTUNE Cruciate Retaining (CR), Posterior Stabilized (PS) and Revision Femoral C
P830055/S372 · FDA decision
30-Day Notice
P830055/S376 · Related supplement
Attune Rotating Platform (RP) Total Knee System and the DePuy P.F.C. Sigma Rotating Platform (RP) Total Knee System an
P830055/S351 · Related supplement
Attune Revision Knee System
P830055/S375 · Related supplement
LCS Total Knee System
P830055/S380 · Related supplement
LCS Total Knee System
P830055/S377 · Related supplement
ATTUNE Rotating Platform (RP) Total Knee System, ATTUNE Revision Rotating Platform (RP) Total Knee System, and M.B.T. Re
P830055/S379 · Related supplement
ATTUNE Revision Knee System
P830055/S378 · Related supplement
LCS Knee System
P830055/S381 · Related supplement
ATTUNE Rotating Platform (RP) Total Knee System, and ATTUNE Revision Rotating Platform (RP) Knee System
Timeline entries are records held by MedtechLedger for P830055. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P830055
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Depuy, Inc. | PMA supplement | Sep 3, 2026 | FDA | |
| Depuy, Inc. | PMA supplement | Sep 10, 2026 | FDA | |
Attune Revision Knee SystemP830055/S351 | Depuy, Inc. | PMA supplement | Sep 21, 2026 | FDA |
LCS Total Knee SystemP830055/S375 | Depuy, Inc. | PMA supplement | Sep 25, 2026 | FDA |
LCS Total Knee SystemP830055/S380 | Depuy, Inc. | PMA supplement | Oct 5, 2026 | FDA |
| Depuy, Inc. | PMA supplement | Oct 8, 2026 | FDA | |
ATTUNE Revision Knee SystemP830055/S379 | Depuy, Inc. | PMA supplement | Oct 9, 2026 | FDA |
LCS Knee SystemP830055/S378 | Depuy, Inc. | PMA supplement | Oct 27, 2026 | FDA |
| Depuy, Inc. | PMA supplement | Oct 27, 2026 | FDA |
Explore the linked device profile
Other records with product code NJL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
NexGen LPS-Flex/LPS Mobile Bearing Knee SystemP060037/S100 | Zimmer, Inc. | PMA supplement | Oct 16, 2026 | FDA |
| Zimmer, Inc. | PMA supplement | Sep 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Depuy, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- P.O. Box 988, 700 Orthopaedic Dr., Warsaw, IN, 46581
Sources and methodology
- Original FDA record: P830055/S372
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





